228
Views
3
CrossRef citations to date
0
Altmetric
Original

IS THERE A NEED FOR BLOOD SUBSTITUTES IN THE NEW MILLENNIUM, AND WHAT SHOULD WE EXPECT IN THE WAY OF SAFETY AND EFFICACY? A DEVELOPMENT PERSPECTIVE

, Ph.D.
Pages vii-x | Published online: 11 Jul 2009

REFERENCES

  • Chang T MS. Editorial: Is there a need for blood substitutes in the new millennium and what can we expect in way of safety and efficacy?. Art Cells Blood Sub Immob Biotech 2000; 28: i–vii
  • Alayash A I. Editorial: Is there a need for blood substitutes in the new millennium and what can we expect in way of safety and efficacy?. From a research perspective. Artif. Cells, Blood Sub. Immob. Biotech 2000; 29(1)
  • Hsia J C. Pasteurizable, freeze-driable hemoglobin-based blood substitute. US Patent No. 4,857,626, 1989
  • Hsia J C. Compositions and methods using nitroxides to avoid oxygen toxicity, particularly in stabilized, polymerized, conjugated or encapsulated hemoglobin used as a red cell substitute. US Patent No. 5,591,710, 1997
  • D'Agnillo F, Chang T M. Polyhemoglobin-superoxide dismutase-catalase as a blood substitute with antioxidant properties. Nat Biotechnol 1998; 16(7)667–71
  • Okayama N, Park J H, Coe L, Granger D N, Ma L, Hsia C J, Alexander J S. Polynitroxyl αα-hemoglobin (PNH) inhibits peroxide and superoxide-mediated neutrophil adherence to human endothelial cells. Free Radic Res 1999; 31(1)53–8
  • McLeod L L, Alayash A I. Detection of a ferrylhemoglobin intermediate in an endothelial cell model after hypoxia-reoxygenation. Am J Physiol 1999; 277(1 Pt 2)92–9
  • Krishna M C, Samuni A, Taira J, Goldstein S, Mitchell J B, Russo A. Stimulation by nitroxides of catalase-like activity of hemeproteins. Kinetics and mechanism. J Biol Chem 1996; 271(42)26018–25
  • Krishna M C, Ma L, Samuni A, Trimble C E, Mitchell J B, Hsia C JC. Superoxide Dismutase- and Catalase-Mimetic Activity of a Polynitroxyl Hemoglobin (PNH). Artif. Cells, Blood Sub. Immob. Biotech 1996; 24: 369
  • Faivre-Fiorina B, Caron A, Labrude P, Vigneron C. Erythrocyte, plasma and substitute hemoglobins facing physiological oxidizing and reducing agents. Ann Biol Clin (Paris) 1998; 56(5)545–56
  • Samuni A, Karmeli F, Moshen M, Rachmilewitz D. Mechanisms underlying gastric anti-ulcerative activity of nitroxides in rats. Free Rad Res 1999; 30(2)133–40
  • Kentner R, Ma L, Behringer W, Safer P, Hsia C JC, Tisherman S. Antioxidant polynitroxylated albumin (PNA) plus tempol for hemorrhagic shock(HS) in rats: improved survival with early treatment (submitted for publication)
  • Saetzler R K, Arfors K E, Tuma R F, Vasthare U, Ma L, Hsia C J, Lehr H A. Polynitroxylated hemoglobin-based oxygen carrier: inhibition of free radical-induced microcirculatory dysfunction. Free Radic Biol Med. 1999; 27(1–2)1–6
  • Patel P M, Harada H, Ma L, Trimble C E, Hsia C JC. Polynitroxyl hemoglobin (PNH) reduces cerebral infraction following transient cerebral artery occlusion in the HRS rat. Shock 1998; 9: 61
  • Eich R F, Li T, Lemon D D, Doherty D H, Curry S R, Aitken J F, Mathews A J, Johnson K A, Smith R D, Phillips G N, Jr., Olson J S. Mechanism of NO-induced oxidation of myoglobin and hemoglobin. Biochemistry 1996; 35(22)6976–83
  • Haney C R, Buehler P W, Gulati A. Purification and chemical modifications of hemoglobin in developing hemoglobin based oxygen carriers. Adv Drug Deliv Rev 28 2000; 40(3)153–69
  • Jia L, Bonaventura C, Bonaventura J, Stamler J S. s-Nitrosohaemoglobin: a dynamic activity of blood involved control. Nature 1999; 380(6571)221–6
  • Buehler P, Ma L, Trimble C E, Hsia C JC, Gulati A. Dextran conjugation of polynitroxylated -crosslinked hemodynamics and outcome of hemorrhaged rats. Shock 2000; 13: 56
  • Winslow R M. Blood substitutes: refocusing an elusive goal. British J Heamatology 2000; 111: 1–11
  • Tam S C, Blumenstein J, Wong J T. Blood replacement in dogs by dextran-hemoglobin. Can J Biochem 1978; 56(10)981–4

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.